Models for open innovation in the pharmaceutical industry-Reference-Cited by-同舟云学术

Models for open innovation in the pharmaceutical industry

Published:2013-12 Issue:23-24 Volume:18 Page:1133-1137
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Schuhmacher Alexander,Germann Paul-Georg,Trill Henning,Gassmann Oliver

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference18 articles.

1. The 2012 EU Industrial R&D Investment Scoreboard;European Commission Joint Research Centre, Directorate General Research,2012

2. Pharmaceutical Industry 2011 Profile;Pharmaceutical Research and Manufacturers of America (PhRMA),2011

3. The Pharmaceutical Industry and Global Health: Facts and Figures;International Federation of Pharmaceutical Manufacturers & Associations (IFPMA),2011

4. How to improve R&D productivity: the pharmaceutical industry's grand challenge;Paul;Nat. Rev. Drug Discov.,2010

5. Deconstructing the drug development process: the new face of innovation;Kaitin;Clin. Pharmacol. Ther.,2010

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing open innovation in a closed biopharmaceutical industry;African Journal of Science, Technology, Innovation and Development;2024-07-12

2. Research and development intensity, inventory leanness, and firm performance;Journal of Open Innovation: Technology, Market, and Complexity;2024-06

3. Productivity of the Korean Biopharmaceutical Industry: Exploring the Effect of Business Model and Open Innovation;Science, Technology and Society;2024-05-13

4. Making more of less: using divestitures to unlock pharmaceutical innovation;Drug Discovery Today;2024-04

5. The rise of spin-offs: Fueling pharmaceutical innovation through collaboration;Journal of Open Innovation: Technology, Market, and Complexity;2024-03